Addition of a progestin for 10-12 days each month to
estrogen replacement therapy in menopausal women
is recommended because the progestin:
A. Blocks the increased risk of myocardial
infarction due to estrogen
B. Blocks the increased risk of endometrial
carcinoma due to estrogen
C. Reverses vulval atrophy occurring in postmenopausal women
D. Enhances the metabolic benefits of estrogen
treatment
estrogen replacement therapy in menopausal women
is recommended because the progestin:
A. Blocks the increased risk of myocardial
infarction due to estrogen
B. Blocks the increased risk of endometrial
carcinoma due to estrogen
C. Reverses vulval atrophy occurring in postmenopausal women
D. Enhances the metabolic benefits of estrogen
treatment